Optimus too could launch Covid pill Paxlovid soon

The company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator this week for a review, said people aware of the matter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Uq4CgM2
via IFTTT